Logo Unión Europea

Olanzapine RC A (USP); Olanzapine Impurity A (EP)

GA01137 - 98%


In stock
Delivery: 3 to 5 working days
Others quantities on request

Specifications

  • Description

    GA01137

    Olanzapine (originally branded Zyprexa) is an atypical antipsychotic. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder. It is structurally similar to clozapine and quetiapine. It is a dopamine antagonist and is classified as a thienobenzodiazepine.

    We have successfully synthesized impurities of the Olanzapine. This will be of interest to pharmaceutical companies and analytical labs.

  • Additional information
    Packing Unit

    1 g, 500 mg

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.